New York University School of Medicine, New York;
Mount Sinai Medical Center, New York, NY
Objective: Histologic diagnosis of mucosal melanoma of the head and neck can be difficult, requiring immunohistochemical stains. Our objective was to report staining characteristics of several antibodies, including a novel marker, PNL2, which has not been examined in mucosal melanoma.
Design: Pathologic specimens of primary mucosal melanomas of the head and neck were obtained, and immunohistochemical staining with 4 antibodies was performed.
Wen YH, Morris LG, Nonaka D, Kutler DI, Huan Y, Wang BY. P039 PNL2 Melanocytic Marker in Immunohistochemical Evaluation of Primary Malignant Mucosal Melanoma of the Head and Neck. Arch Otolaryngol Head Neck Surg. 2006;132(8):872–873. doi:10.1001/archotol.132.8.872-c
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: